89bio Current Cash

89bio (ETNB) currently reports a current cash of $130M as of June 2025. That compares with $210M in the prior-year period — down 39.2% year over year. Use the charts on this page to explore 89bio's current cash history and peer comparisons.

89bio's current cash decreased from $210M to $130M — a 39.2% year-over-year decrease (period ending June 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

89bio reported $130M in current cash as of June 2025. That compares with $210M in the prior-year period — down 39.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $130M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for 89bio, and consider following ETNB for alerts when major investors trade the stock.

89bio is classified in the Healthcare sector. On current cash, it currently shows $130M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ETNB with unrelated industries.